Michael Leisch

Michael Leisch is a researcher affiliated with the Department of Internal Medicine III - Division of Hematology, Medical Oncology, and related fields. His work focuses on tumor biology, pharmacology, and genomic analysis in hematologic malignancies and myeloid disorders.

• Research output spans 2015-2025 (23 total publications)
• Key areas: Circulating Tumor DNA, Biological Markers, Neoplasm Genetics
• Active in clinical trials and treatment safety for azacitidine and CAR-T therapy

Current research involves next-generation sequencing applications, tumor burden monitoring via cell-free DNA, and outcome prediction in myeloid malignancies. His work integrates clinical practice with genomic analysis to improve patient care.

Collaborates with the Austrian Myeloid Registry (AGMT) and Austrian CAR-T Network. Projects include biomarker development for head and neck cancer (2017-2018) and precision treatment strategies for rare hematologic syndromes like VEXAS.